Genetics-based drug discovery: Some stories from the frontline

Add to your list(s) Download to your calendar using vCal

• Matt Tudball (5 Prime Sciences)
• Tuesday 27 February 2024, 13:00-14:00
• MR5, Centre for Mathematical Sciences, Wilberforce Road, Cambridge.

If you have a question about this talk, please contact Qingyuan Zhao.

Human genetics has become an increasingly popular means of identifying modifiable therapeutic targets for disease. For the last 16 months, I have been working at a start-up that partners with biotech, venture capital and pharma companies to interrogate their drug candidates and identify new ones using human genetic and multi-omic data. This experience has sharpened my perspective on the value of human genetics in this space. I will share some projects from the last year that I believe highlight the scientific (and, in some cases, very human) challenges and potential of genetics-based drug discovery. Any client confidential information will be withheld to ensure compliance with all relevant CDAs.

This talk is part of the Causal Inference Reading Group series.

This talk is included in these lists:

• All CMS events
• All Talks (aka the CURE list)
• CMS Events
• Causal Inference Reading Group
• DPMMS Lists
• DPMMS info aggregator
• DPMMS lists
• Hanchen DaDaDash
• Interested Talks
• MR5, Centre for Mathematical Sciences, Wilberforce Road, Cambridge
• School of Physical Sciences
• Statistical Laboratory info aggregator
• bld31

Note that ex-directory lists are not shown.